Chronic lymphocytic leukemia (CLL) is a slow-growing blood cancer that begins in the bone marrow and affects a type of white blood cell called lymphocytes. As abnormal lymphocytes accumulate in the blood, bone marrow, and lymph nodes, they can interfere with the body's ability to fight infections and produce healthy blood cells. Many people with CLL are diagnosed during routine blood tests before symptoms appear. Advances in targeted therapies and personalized treatment have significantly improved outcomes for many individuals living with CLL.
CLL develops when abnormal B lymphocytes grow and survive longer than normal.
Over time, these abnormal cells can:
CLL is one of the most common types of leukemia in adults and typically progresses slowly.
Some people have no symptoms at diagnosis, while others may experience:
Symptoms vary depending on the stage and activity of the disease.
Factors associated with an increased risk of CLL include:
The exact cause of CLL is not fully understood, and many people have no identifiable risk factors.
Diagnosis typically involves several laboratory and imaging tests, including:
These tests help confirm the diagnosis and guide treatment planning.
Not everyone with CLL requires immediate treatment. Individuals without symptoms may be monitored through an approach known as active surveillance or watchful waiting.
When treatment becomes necessary, options may include:
Treatment recommendations depend on disease stage, genetic findings, symptoms, and overall health.
Regular follow-up appointments help assess disease progression and treatment response.
Monitoring may include:
Routine monitoring helps determine when treatment should begin or be adjusted.
Many people with CLL live for years with careful medical management.
Healthy habits that support overall well-being include:
These measures complement medical treatment and ongoing monitoring.
Prompt medical evaluation is recommended if symptoms include:
Early evaluation can help identify disease progression or treatment-related complications.
Chronic lymphocytic leukemia is a slow-growing blood cancer that often requires individualized care and long-term monitoring. While some people may not need immediate treatment, others benefit from modern targeted therapies, immunotherapy, and other advanced treatment approaches. Early diagnosis, regular follow-up, and personalized care from a hematology specialist play important roles in managing CLL and maintaining quality of life.